• Explore /
  • Poster
  • / Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase II study with panitumumab (FFCD 0904).

Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase II study with panitumumab (FFCD 0904).

Abstract Poster

Authors

null

Thomas Aparicio

Department of Gastroenterology, Saint Louis Hospital, Paris, France

Thomas Aparicio , Philippe Ronchin , Louis Bazire , Karine Le Malicot , Claire Lemanski , Xavier Mirabel , Pierre-Luc Etienne , Astrid Lièvre , Wulfran Cacheux , Ariane Darut-Jouve , Christelle De La Fouchardiere , Gilles Breysacher , Delphine Argo Leignel , Alexandre Tessier , Nicolas Magne , Meher Ben Abdelghani , Come Lepage , Veronique Vendrely

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Anal Cancer

Clinical Trial Registration Number

NCT01581840

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3570)

DOI

10.1200/JCO.2019.37.15_suppl.3570

Abstract #

3570

Poster Bd #

62

Abstract Disclosures

Similar Posters

First Author: Hirva Mansurali Mamdani

First Author: Manabu Muto

First Author: Jose Gerard Monzon

First Author: Soyeong Jun